24 May 2013
Keywords: antisoma, find, funds, reap, benefits, pemtumomab, uk
Article | 14 January 2002
Antisoma of the UK says that amendments have been made to its existinglicensing deal with US drug major Abbott Laboratories ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 January 2002
7 January 2002
23 May 2013
© 2013 thepharmaletter.com